Regional Impact of Prophylaxis With the Monoclonal Antibody Palivizumab on Ospitalizations from Respiratory Syncytial Virus in Infants. Swiss Med Wkly 2001, 131 (1112), 146-151. https://doi.org/10.4414/smw.2001.09681.